Skip to main content

Table 4 Rheumatologist’s perception of the role of the Brazilian Consensus in clinical practice

From: Rheumatologist perspective of the Brazilian consensus for detection of auto antibodies in HEp-2 CELLS

Geographic Macro-Region

N

NE

CO

S

SE

SR

Total

Number of rheumatologists

18 (4%)

72 (17%)

37 (9%)

52 (13%)

230 (56%)

5 (1%)

414 (100%)

Do you rely on BCA recommendations to support clinical correlations? *

 Yes

13 (72%)

64 (89%)

33 (89%)

46 (88%)

193 (84%)

5 (100%)

354 (86%)

 No

3 (17%)

6 (8%)

1 (3%)

5 (10%)

29 (13%)

0 (0%)

44 (10%)

 Did not answer

2 (11%)

2 (3%)

3 (8%)

1 (2%)

8 (3%)

0 (0%)

16 (4%)

Did BCA make the understanding of the report clearer? **

 Yes

15 (83%)

60 (83%)

29 (78%)

40 (77%)

168 (73%)

3 (60%)

315 (76%)

 No

1 (6%)

2 (3%)

1 (3%)

4 (8%)

19 (8%)

2 (40%)

29 (7%)

 Did not answer

2 (11%)

10 (14%)

7 (19%)

8 (15%)

43 (19%)

0 (0%)

70 (17%)

Has the Consensus made clinical correlations clearer? ***

 Yes

14 (78%)

61 (85%)

28 (76%)

43 (83%)

172 (75%)

3 (60%)

321 (78%)

 No

1 (5%)

2 (3%)

2 (5%)

0 (0%)

14 (6%)

2 (40%)

21 (5%)

 Did not answer

3 (17%)

9 (12%)

7 (19%)

9 (17%)

44 (19%)

0 (0%)

72 (17%)

  1. N North, NO Northeast; CO Midwest; S South; SE Southeast, SR No region.
  2. Chi-square test: *p = 0.329, **p = 0.386, ***p = 0.59